FIELD: pharmaceutics.
SUBSTANCE: disclosed is a method of producing a liquid oral pharmaceutical formulation in which the unpleasant taste of ibuprofen is reduced, which contains (A) ibuprofen, or a salt thereof, or a solvate thereof, and (B) magnesium oxide, where the weight ratio [(B)/(A)] of component (A) and component (B) is 0.2–1.5.
EFFECT: disclosed is a technology for reducing the unpleasant taste of ibuprofen in oral pharmaceutical formulations containing ibuprofen.
6 cl, 9 tbl, 20 ex
Authors
Dates
2024-05-31—Published
2019-11-15—Filed